日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enzymatic Remodelling of Tumour Microenvironment Enhances Anti-CEACAM5 CAR T-Cell Efficacy Against Colorectal Cancer

肿瘤微环境的酶促重塑增强抗CEACAM5 CAR T细胞对结直肠癌的疗效

Banik, Debasis; Ward, Christopher J; Chakraborty, Soura; Zhang, Ziwei; Heraghty, Daniel; Suresh, Prasanna; Li, Bing; Kedia, Shekhar; Pramanik, Jhuma; Davis, Simon J; Roy, James P; Chapman, Michael A; Mahata, Bidesh; Klenerman, David

The Landscape of CEACAM5 Expression by Immunohistochemistry in NSCLC

非小细胞肺癌中CEACAM5表达的免疫组织化学分析

Hsu, Ying-Han R; Almutrafi, Amna; Hueniken, Katrina; Azaizeh, Alhareth; Hou, Likun; Li, Quan; Bates, Mackenzie; Pham, Nhu-An; Tsao, Ming-Sound

Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trial

Precemtabart tocentecan(一种抗CEACAM5抗体药物偶联物)治疗转移性结直肠癌:一项I期临床试验

Kopetz, Scott; Boni, Valentina; Kato, Ken; Raghav, Kanwal P S; Vieito, Maria; Pallis, Athanasios; Habermehl, Christina; Siddiqui, Abdul; Courlet, Perrine; Sloot, Willem; Raab-Westphal, Sabine; Hart, Felix; Rodriguez-Rivera, Ildefonso

Rapid diagnostic imaging and targeted immunotoxin delivery in aggressive prostate cancer using CEACAM5-specific nanobodies

利用CEACAM5特异性纳米抗体对侵袭性前列腺癌进行快速诊断成像和靶向免疫毒素递送

Zhaoming Xiao # ,Jingbo Ma # ,Jinpeng Cen # ,Tao Xie # ,Liuhai Zheng ,Guangwei Shi ,Zhifen Li ,Yang Li ,Chengming Qu ,Yuanqiao He ,Chong Wang ,Jun Xiao ,Haibo Jiang ,Zhijie Li ,Jigang Wang ,Shan-Chao Zhao

Binding of Fusobacterium nucleatum autotransporter adhesin CbpF to human CEACAM1 and CEACAM5: A Velcro model for bacterium adhesion

具核梭杆菌自转运蛋白黏附素CbpF与人CEACAM1和CEACAM5的结合:细菌黏附的尼龙搭扣模型

Shen, Fan; Li, Linjie; Yang, Dongchun; Tang, Zhexiao; Zhang, Lu; Liu, Kefang; Hou, Wenzhe; Lu, Zhuozhuang; Fang, Jing-Yuan; Qi, Jianxun; Zhao, Xin; Gao, George F

ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell-Dependent Tumor Immunity and Synergizes with PD-1 Blockade

ATOR-4066 是一种靶向 CD40 和 CEACAM5 的双特异性抗体,可诱导强烈的髓系和 T 细胞依赖性肿瘤免疫,并与 PD-1 阻断剂产生协同作用。

Hampus Andersson ,Ida Uddbäck ,Tova Hermodsson ,Mona Celander ,Amulya Krishna Shetty ,Lill Ljung ,Anneli Nilsson ,Anette Sundstedt ,Laura von Schantz ,Laura A Varas ,Mattias Levin ,Anna Säll ,Dietmar Weilguny ,Kim Jansson ,Sara Fritzell ,Karin Hägerbrand ,Malin Lindstedt # ,Peter Ellmark #

Optimizing efficacy and safety of T cell bispecific antibodies: the interdependence of CD3 and tumor antigen binder affinities in FOLR1 and CEACAM5 2 + 1 TCBs

优化T细胞双特异性抗体的疗效和安全性:FOLR1和CEACAM5 2+1 TCB中CD3和肿瘤抗原结合亲和力的相互依赖性

Abdelmotaleb, Omar; Schneider, Anneliese; Waldhauer, Inja; Sam, Johannes; Hofer, Thomas; Lechmann, Martin; Freimoser-Grundschober, Anne; Giusti, Anna Maria; Essig, Katharina; Nikic, Tijana; Steinacher, Linda; Gassner, Christian; Märsch, Stephan; Bransi, Ali; Odermatt, Alex; Brünker, Peter; Colombetti, Sara; Klein, Christian

MiR-5095 inhibits proliferation, migration, and invasion of gastric cancer cells by targeting CEACAM5

miR-5095通过靶向CEACAM5抑制胃癌细胞的增殖、迁移和侵袭。

Lin, Wan; Cai, Ruizhi; Fan, Weining; Zhang, Xiaoxu; He, Fang; Miao, Yu; Qian, Haiquan; Zhao, Wanli; Zhu, Yongchao

CEA-4-1BBL: CEACAM5-Targeted 4-1BB Ligand Fusion Proteins for Cis Co-Stimulation with CEA-TCB.

CEA-4-1BBL:靶向 CEACAM5 的 4-1BB 配体融合蛋白,用于与 CEA-TCB 进行顺式共刺激。

Claus Christina, Ferrara-Koller Claudia, Sam Johannes, Lang Sabine, Albrecht Rosmarie, Buser Regula B, Bommer Esther, Sala Grégory La, Nicolini Valeria G, Colombetti Sara, Bacac Marina, Umaña Pablo, Klein Christian

Mutations of the CEACAM5 Gene PELPK Motif in Patients With Appendiceal or Colorectal Adenocarcinoma

阑尾或结直肠腺癌患者中CEACAM5基因PELPK基序的突变

Cristaudo, Adam Thomas; Barat, Shoma; Ahmadi, Nima; Morris, David